newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event

NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,